Denali Therapeutics Inc. (NASDAQ: DNLI), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tividenofusp alfa (DNL310) for the treatment ...

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

Denali obtains Breakthrough Therapy Designation for its experimental candidate, tividenofusp alfa (DNL310), for the treatment of pateints with Hunter syndrome.

Robert W. Baird assumed coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a research note released on ...

President Volodymyr Zelenskyy has explained in detail in his response to the petition why members of the Verkhovna Rada are ...

On a recent visit to Washington DC, Ho sat down with GEN Editorial Director Kevin Davies, PhD, to discuss Denali’s progress ...

Denali Therapeutics (NASDAQ:DNLI – Free Report) had its price objective cut by HC Wainwright from $90.00 to $87.00 in a ...

JCR Pharmaceuticals Co., Ltd. (TOKYO:4552; “JCR”) and Modalis Therapeutics Corporation (TOKYO:4883; “Modalis”) today announced that they have validated the initial proof of concept in a joint research ...

An update from JCR Pharmaceuticals Co., Ltd. ( (JP:4552) ) is now available.

The most significant discussion of AI safety was published by the BBC earlier this month amid its otherwise somewhat trivial festive offerings. Much to think about on the perils of misalignment in ...

Delhi BJP MPs propose projects to ease traffic congestion and pollution, connecting expressways and creating direct routes.

Public will not have to change lives ‘radically’ for climate goal, MPs promised - Lifestyle change, such as diet and travel, ...